Sumitomo dainippon pharma oncology：rearrangement or Nucleophosmin 1 (NPM1) Mutation
rearrangement or Nucleophosmin 1 (NPM1) Mutation
2022年3月29日—SumitomoDainipponPharmaOncologyAnnouncesFirstPatientDosedinPhase1/2StudyofDSP-5336inPatientswithAcuteLeukemiawithand ...。其他文章還包含有：「AboutUs」、「ContactUs」、「LeadershipTeam」、「LifeatSMPOncology」、「News&Media」、「OurPipeline」、「SumitomoDainipponPharmaOncologyAnnouncesIts...」、「SumitomoPharmaOncology」、「SumitomoPharmaOncology」
查看更多 離開網站
About Us
https://oncology.sumitomo-phar
Sumitomo Pharma Oncology is a global developer of novel cancer therapeutics with one goal: advancing purposeful science by transforming new discoveries into ...
Contact Us
https://oncology.sumitomo-phar
Contact us. Sumitomo Pharma Oncology. We are always interested in hearing from you. Please find contact information below the map, or complete the Inquiries ...
Leadership Team
https://oncology.sumitomo-phar
Leadership. A model for success. We are led by a team of passionate and respected experts with proven track records of success in drug discovery and ...
Life at SMP Oncology
https://oncology.sumitomo-phar
If you want to have an impact on the lives of patients with cancer, take a look at Sumitomo Pharma Oncology (SMP Oncology). With our diverse pipeline, ...
News & Media
https://oncology.sumitomo-phar
Sumitomo Dainippon Pharma Oncology, Inc., a clinical-stage pharmaceutical company focused on research and development for novel cancer therapeutics, today ...
Our Pipeline
https://oncology.sumitomo-phar
Discover our pipeline of targeted therapies. Sumitomo Pharma Oncology is advancing cancer treatments for novel pathways in solid tumors and hematologic ...
Sumitomo Dainippon Pharma Oncology Announces Its ...
https://www.prnewswire.com
The merger of Tolero Pharmaceuticals and Boston Biomedical, and the formation of Sumitomo Dainippon Pharma Oncology, will help us achieve our ...
Sumitomo Pharma Oncology
https://www.linkedin.com
Our robust and diverse pipeline spans multiple areas, including oncogenic pathways, survival mechanisms and novel protein interactions, which aim to address ...
Sumitomo Pharma Oncology
https://oncology.sumitomo-phar
Sumitomo Pharma Oncology is a global developer of novel cancer therapeutics dedicated to the promise of purposeful science in oncology.